Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 32 Pain, Postoperative 18 Neoplasms 16 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Lung Neoplasms 12 Brain Neoplasms 12 Prostatic Neoplasms 9 Ovarian Neoplasms 9 Colonic Neoplasms 8 Carcinoma, Hepatocellular 8 Stomach Neoplasms 7 Depression 7 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Pain 6 Head and Neck Neoplasms 6 Thyroid Neoplasms 5 Pancreatic Neoplasms 5 Multiple Myeloma 5 Leiomyoma 5 Agnosia 5 Neoplasm Metastasis 4 Lymphoma 4 Fatigue 4 Delirium 4 Anxiety Disorders 4 Urinary Bladder Neoplasms 3 Thromboembolism 3 Supratentorial Neoplasms 3 Stomatitis 3

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 3 Pancreaticoduodenectomy 2 Oxaliplatin 2 Irinotecan 2 titanium silicide 1 tislelizumab 1 sonidegib 1 paricalcitol 1 mitazalimab 1 lenvatinib 1 ivosidenib 1 irinotecan sucrosofate 1 glucoraphanin 1 devimistat 1 Transurethral Resection of Prostate 1 Tissue Banks 1 Taxes 1 Specimen Handling 1 Saline Solution 1 S 1 (combination) 1 Ropivacaine 1 Robotic Surgical Procedures 1 Radiomics 1 Positron Emission Tomography Computed Tomography 1 Parturition 1 PEGPH20 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Losartan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Ductal Adenocarcinoma × Saline Solution × Clear all

NCT06214533 2024-01-19

CEBOIDS

Sixth Affiliated Hospital, Sun Yat-sen University

Phase NA Unknown

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡